Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11974983 Lasofoxifene treatment of breast cancer

Patent 11974983 was granted and assigned to Duke University on May, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Duke University

0

Current Assignee

Duke University

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Donald P. McDonnell0

Kaitlyn Andreano0

Stephanie L. Gaillard0

Ching-yi Chang0

Date of Patent

May 7, 2024

0

Patent Application Number

179345750

Date Filed

September 22, 2022

0

Patent Citations

US Patent 7553500 Pharmaceutical composition having uniform drug distribution and potency

0

US Patent 9018244 Benzopyran compounds, compositions and uses thereof

0

US Patent 9204286 System and method of branding and labeling a mobile device

0

US Patent 10231978 Anordrin compositions and methods for treating diseases

0

US Patent 10258604 Lasofoxifene treatment of breast cancer

0

US Patent 10624874 Lasofoxifene modulation of membrane-initiated estrogen signals and methods for tumor treatment

0

US Patent 11497730 Lasofoxifene treatment of breast cancer

0

US Patent 10905659 Lasofoxifene treatment of breast cancer

0

...

Patent Primary Examiner

Raymond J. Henley, III

0

CPC Code

0

0

Patent abstract

The disclosure provides methods for treating estrogen receptor positive (ER

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11974983 Lasofoxifene treatment of breast cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.